Supplementary Table S4 from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers Jingjing Jiang , Lingyan Jiang , Benjamin J. Maldonato , Yingyun Wang , Matthew Holderfield , Ida Aronchik , Ian P. Winters , Zeena Salman , Cristina Blaj , Marie Menard , Jens Brodbeck , Zhe Chen , Xing Wei , Michael J. Rosen , Yevgeniy Gindin , Bianca J. Lee , James W. Evans , Stephanie Chang , Zhican Wang , Kyle J. Seamon , Dylan Parsons , James Cregg , Abby Marquez , Aidan C.A. Tomlinson , Jason K. Yano , John E. Knox , Elsa Quintana , Andrew J. Aguirre , Kathryn C. Arbour , Abby Reed , W. Clay Gustafson , Adrian L. Gill , Elena S. Koltun , David Wildes , Jacqueline A.M. Smith , Zhengping Wang , Mallika Singh crossref（2024）
摘要
Supplementary Table S4 shows % mean tumor volume change, % mean body weight change of RMC-6236 treatment group on mRECIST response calling date; and PPIA mRNA expression levels of each xenograft model in RMC-6236 mouse clinical trial.
更多 查看译文
AI 理解论文
溯源树
样例
